E-DRUG: Access to Medicines Index presents final model
-------------------------------------------------
An important milestone has been reached with the publication of the
Industry and Stakeholder Review report and associated AtM performance
model. This model will be the basis for the Access to Medicine (AtM)
Index, ranking the largest pharmaceutical companies on their performance
in access to medicine. The Index will be produced by Innovest Strategic
Value Advisors together with the Access to Medicine Foundation, and will
be released in spring 2008.
PARTNERS IN A GLOBAL VENTURE
The Access to Medicine Index (AtM Index) framework is part of a global
initiative to improve access to medicines (ATMs) worldwide. The project
aims to highlight that ATMs is the joint responsibility of all
stakeholders involved in improving global health, with pharmaceutical
companies an essential actor in providing access to drugs to those in
need.
A MULTI-STAKEHOLDER AND COLLABORATIVE PROJECT
Feedback from ATMs stakeholders was received through three consultation
phases. The first phase gathered the views of a wide range of experts
from NGOs, investors, governments, consultants and academics. The second
phase was focused on getting the pharmaceutical industry perspective on
the initial findings. The third period allowed further input on the
framework from both the industry and its stakeholders.
INDEX EVOLUTION
The report incorporates as many suggestions as possible from the experts
contacted during the three consultation periods. It also presents the
final list of Criteria, Indicators, Metrics and Weightings that will be
used to benchmark company performance with regard to ATMs. The AtM Index
will be the result after an evaluation and ranking of 20 companies, to
be published in spring 2008.
TOOLKIT FOR ALL STAKEHOLDERS
The forthcoming Index will serve as a tool to aid the pharmaceutical
industry and its stakeholders in shaping access to medicine policies and
strategies. Investors can use the Index as an indicator of access to
medicine performance, which can then be included in investment analysis.
For the global health sector, the Index is a means to improve the
effectiveness of partnerships with the pharmaceutical industry.
To download the Industry and Stakeholder Review: www.atmindex.org
FOR MORE INFORMATION
Wim Leereveld
Martijn van Rijnsoever
Access to Medicine Index
Spaarne 35
2011 CD Haarlem, the Netherlands
Tel +31 (0)23 53 39 187
www.atmindex.org
info@atmindex.org
"Martijn van Rijnsoever" <mvrijnsoever@atmindex.org>